Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study - Top-Institutions - MDSpire

Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study

By
Xiao-Jue Huang
Liu-Hui Mo
Ke-Jun Wu
Rong-Quan He
Hui Li
Gang Chen
Li-Min Liu
May 12, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
#2

Memorial Sloan Kettering Cancer Center

New York, New York
Key Differentiators
- Oncology
#3

Sun Yat-sen University

Guangzhou, Guangdong
Key Differentiators
- Oncology
#4

St. Jude Children’s Research Hospital

Memphis, Tennessee
Key Differentiators
- Oncology
#5

Charite–Universitatsmedizin Berlin

Berlin, Germany
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Oncology

Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study

by Xiao-Jue Huang, Liu-Hui Mo, Ke-Jun Wu, Rong-Quan He, Hui Li, Gang Chen, Li-Min Liu
May 12, 2026

Related Content

Frontiers In Immunology

Cytokine and chemokine networks in colorectal cancer

by Xuhui Zhang, Ying Zhang, Rong Wang
May 20, 2026

Surgical Endoscopy

SAGES colorectal and metabolic bariatric surgery committee joint task force call to action for synchronized severe obesity and colorectal cancer management

Frontiers In Oncology

Changes in dietary habits following a colon cancer diagnosis: insights from the prospective ECHO (Eating habits CHanges in Oncologic patients) STUDY 2.0